The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- GI 2.0: The Playbook | Chapter 3 | The Assets You Already Own
- Microbiome: Overhyped and underutilized?
- AI adoption surges, but providers worry about deskilling (Healthcare Dive)
- The gastroenterologist pay gap (Becker’s GI & Endoscopy)
- 8 No Surprises Act shake-ups physicians need to know (Becker’s Healthcare)
- ChristianaCare researchers identify genetic drivers of aggressive CRC (Becker’s GI & Endoscopy)
- A Collaborative Approach for Advanced IBD Therapy Prior Authorization Denials (GI & Endoscopy News)
- Personalized Nutrition: The Future of Gastroenterology (Grand View Research)
